Aseptically Prepared Systemic Anti-Cancer Therapy Medicines
key details
| Value | £850,000,000 |
|---|---|
| Status | active |
| Category (CPV) | 33600000 |
| Region | East Midlands, West Midlands, South East |
| Deadline | 11 May 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-051cde |
description
This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs, CIVAs, and provisions for stock inventory management and supply of compounded systemic anti-cancer therapy.
documents
- https://www.find-tender.service.gov.uk/Notice/033144-2026 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 22 May 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 024556-2025 |
| 12 Aug 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 048018-2025 |
| 13 Apr 2026 | Tender notice (UK4) | Procurement Act 2023 | 033144-2026 |
more from Mid South Essex NHS Foundation Trust
- Taxi Services Dynamic Market · 22 Jul 2026
- Linen and Laundry · £100,000,000 · 26 May 2026
- FW - Enterprise Solutions for End to End ICT 3 (ESEE 3) · £2,000,000,000 · 26 May 2026
- COMIT4 - ICT Solutions · £6,000,000,000 · 26 May 2026
- Pathology Storage and Scanning Solutions Tender Notice · £120,000,000 · 15 May 2026
- Lot 1 Recruitment Solutions including Employment ATS Onboarding and Vetting · £45,000,000 · 14 May 2026
- Lot 2. Reward Solutions including Salary Sacrifice and Vehicle Leasing · £145,000,000 · 14 May 2026
- Lot 3 Retention Solutions including Professional Development, Mandatory Training, Training Assessments and LMS · £145,000,000 · 14 May 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.